Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis

Although there is no evidence for a role of anti-MOG antibodies in adult MS, no information on B lymphocytes with MOG-committed BCR is available. We report here on the frequency of anti-MOG B cells forming rosettes with polystyrene beads (BBR) covalently bound to the extracellular domain of rhMOG in...

Full description

Saved in:
Bibliographic Details
Main Authors: Annie Elong Ngono, Maud Lepetit, Markus Reindl, Alexandra Garcia, Flora Guillot, Athénaïs Genty, Mélanie Chesneau, Marion Salou, Laure Michel, Fabienne Lefrere, Kathrin Schanda, Berthe-Marie Imbert-Marcille, Nicolas Degauque, Arnaud Nicot, Sophie Brouard, David-Axel Laplaud, Jean-Paul Soulillou
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/673503
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545924593745920
author Annie Elong Ngono
Maud Lepetit
Markus Reindl
Alexandra Garcia
Flora Guillot
Athénaïs Genty
Mélanie Chesneau
Marion Salou
Laure Michel
Fabienne Lefrere
Kathrin Schanda
Berthe-Marie Imbert-Marcille
Nicolas Degauque
Arnaud Nicot
Sophie Brouard
David-Axel Laplaud
Jean-Paul Soulillou
author_facet Annie Elong Ngono
Maud Lepetit
Markus Reindl
Alexandra Garcia
Flora Guillot
Athénaïs Genty
Mélanie Chesneau
Marion Salou
Laure Michel
Fabienne Lefrere
Kathrin Schanda
Berthe-Marie Imbert-Marcille
Nicolas Degauque
Arnaud Nicot
Sophie Brouard
David-Axel Laplaud
Jean-Paul Soulillou
author_sort Annie Elong Ngono
collection DOAJ
description Although there is no evidence for a role of anti-MOG antibodies in adult MS, no information on B lymphocytes with MOG-committed BCR is available. We report here on the frequency of anti-MOG B cells forming rosettes with polystyrene beads (BBR) covalently bound to the extracellular domain of rhMOG in 38 relapsing-remitting patients (RRMS) and 50 healthy individuals (HI). We show a substantial proportion of circulating anti-MOG-BBR in both RRMS and HI. Strikingly, MOG-specific B cells frequencies were lower in MS than in HI. Anti-MOG antibodies measured by a cell-based assay were not different between MS patients and controls, suggesting a specific alteration of anti-MOG B cells in MS. Although anti-MOG-BBR were higher in CNS fluid than in blood, no difference was observed between MS and controls. Lower frequency of MOG-BBR in MS was not explained by an increased apoptosis, but a trend for lower proliferative capacity was noted. Despite an efficient B cell transmigration across brain derived endothelial cells, total and anti-MOG B cells transmigration was similar between MS and HI. The striking alteration in MOG-specific B cells, independent of anti-MOG antibody titers, challenges our view on the role of MOG-specific B cells in MS.
format Article
id doaj-art-6ae697d266744128b8d799aebc99bf4b
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-6ae697d266744128b8d799aebc99bf4b2025-02-03T07:24:16ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/673503673503Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple SclerosisAnnie Elong Ngono0Maud Lepetit1Markus Reindl2Alexandra Garcia3Flora Guillot4Athénaïs Genty5Mélanie Chesneau6Marion Salou7Laure Michel8Fabienne Lefrere9Kathrin Schanda10Berthe-Marie Imbert-Marcille11Nicolas Degauque12Arnaud Nicot13Sophie Brouard14David-Axel Laplaud15Jean-Paul Soulillou16INSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceClinical Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, AustriaINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, CIC 004, 44093 Nantes, FranceClinical Department of Neurology, Innsbruck Medical University, 6020 Innsbruck, AustriaFaculté de Médecine, Université de Nantes, 44035 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceINSERM, UMR1064, 44093 Nantes, FranceAlthough there is no evidence for a role of anti-MOG antibodies in adult MS, no information on B lymphocytes with MOG-committed BCR is available. We report here on the frequency of anti-MOG B cells forming rosettes with polystyrene beads (BBR) covalently bound to the extracellular domain of rhMOG in 38 relapsing-remitting patients (RRMS) and 50 healthy individuals (HI). We show a substantial proportion of circulating anti-MOG-BBR in both RRMS and HI. Strikingly, MOG-specific B cells frequencies were lower in MS than in HI. Anti-MOG antibodies measured by a cell-based assay were not different between MS patients and controls, suggesting a specific alteration of anti-MOG B cells in MS. Although anti-MOG-BBR were higher in CNS fluid than in blood, no difference was observed between MS and controls. Lower frequency of MOG-BBR in MS was not explained by an increased apoptosis, but a trend for lower proliferative capacity was noted. Despite an efficient B cell transmigration across brain derived endothelial cells, total and anti-MOG B cells transmigration was similar between MS and HI. The striking alteration in MOG-specific B cells, independent of anti-MOG antibody titers, challenges our view on the role of MOG-specific B cells in MS.http://dx.doi.org/10.1155/2015/673503
spellingShingle Annie Elong Ngono
Maud Lepetit
Markus Reindl
Alexandra Garcia
Flora Guillot
Athénaïs Genty
Mélanie Chesneau
Marion Salou
Laure Michel
Fabienne Lefrere
Kathrin Schanda
Berthe-Marie Imbert-Marcille
Nicolas Degauque
Arnaud Nicot
Sophie Brouard
David-Axel Laplaud
Jean-Paul Soulillou
Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
Journal of Immunology Research
title Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
title_full Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
title_fullStr Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
title_full_unstemmed Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
title_short Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
title_sort decreased frequency of circulating myelin oligodendrocyte glycoprotein b lymphocytes in patients with relapsing remitting multiple sclerosis
url http://dx.doi.org/10.1155/2015/673503
work_keys_str_mv AT annieelongngono decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT maudlepetit decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT markusreindl decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT alexandragarcia decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT floraguillot decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT athenaisgenty decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT melaniechesneau decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT marionsalou decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT lauremichel decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT fabiennelefrere decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT kathrinschanda decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT berthemarieimbertmarcille decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT nicolasdegauque decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT arnaudnicot decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT sophiebrouard decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT davidaxellaplaud decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis
AT jeanpaulsoulillou decreasedfrequencyofcirculatingmyelinoligodendrocyteglycoproteinblymphocytesinpatientswithrelapsingremittingmultiplesclerosis